Tumours with an unmethylated MGMT promoter region, where MGMT is active, have brisk DNA repair mechanisms and are less sensitive to cytotoxic treatment with temozolomide (TMZ), which remains the most effective drug in this tumour. This evidence concerns the gene MGMT and neoplasm.